BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients
NCT01782209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 335
Last updated 2020-07-28
Summary
The objectives of this study is to establish the natural history of BK virus viremia and other possible opportunistic viral pathogens in renal transplants recipients.
Conditions
- BK Virus (BKV) Viremia
Sponsors & Collaborators
-
University of Alabama at Birmingham
lead OTHER
Principal Investigators
-
Richard J Whitley, MD · University of Birmingham at Alabama
-
John W Gnann, MD · Medical University of South Carolina
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
Salivary Replication of BK Virus in Post-kidney Transplant
NCT07256470 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prediction of BK Virus Reactivation in Kidney Transplant Recipient
NCT06219616 ·Status: COMPLETED ·Phase: NA
-
BK Viremia After Renal Transplantation
NCT00684372 ·Status: UNKNOWN ·Phase: NA
-
Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia
NCT05026021 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Pathogenicity and Humoral Immune Response Induced by BK Virus in Lung Transplant Recipients
NCT04164576 ·Status: NOT_YET_RECRUITING
-
BK With VST for Kidney Transplant Patients
NCT05042076 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia
NCT06988072 ·Status: NOT_YET_RECRUITING
-
Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant
NCT02049827 ·Status: COMPLETED ·Phase: NA
-
Ciprofloxacin for Prevention of BK Infection
NCT01789203 ·Status: COMPLETED ·Phase: PHASE4
-
Reduction of BK Viremia in Kidney Transplant Patients
NCT04984902 ·Status: WITHDRAWN ·Phase: NA
-
New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
NCT05264259 ·Status: RECRUITING
-
Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.
NCT04222023 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK
NCT02826811 ·Status: UNKNOWN
-
Validation of Gene Expression Markers of Renal Allograft Functional Decline
NCT01782586 ·Status: COMPLETED
-
Study of Subclinical Viral Infection
NCT01615341 ·Status: UNKNOWN
-
Genomics of Kidney Transplantation
NCT01714440 ·Status: COMPLETED
-
Genital HPV Infections Before and After Renal Transplantation
NCT01717443 ·Status: COMPLETED
-
VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health
NCT03079882 ·Status: COMPLETED
-
Transplant Patient Registry of Liver, Kidney and/or Pancreas
NCT00238693 ·Status: COMPLETED
-
The Study of Long-term Deterioration of Kidney Transplants.
NCT00217126 ·Status: COMPLETED
-
Surveillance Study of Viral Infections Following Lung Transplantation
NCT00701922 ·Status: COMPLETED
-
Development and Validation of a Virtual Biopsy System in Kidney Transplant
NCT04759209 ·Status: UNKNOWN
-
Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients
NCT03880682 ·Status: COMPLETED
-
Respiratory Viral Infections in Pediatric Transplantation
NCT02260596 ·Status: COMPLETED
-
HCV + to HCV - Kidney Transplant
NCT04320290 ·Status: WITHDRAWN ·Phase: PHASE4